BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6757035)

  • 1. [A multicenter trial of treatment with slow-release dihydroergotoxine in chronic senile cerebral insufficiency].
    Franchi F; Di Ruvo R; Guggino G; Mazzanti A; Genga A; Cucinotta D
    G Clin Med; 1982 Jul; 63(7):465-81. PubMed ID: 6757035
    [No Abstract]   [Full Text] [Related]  

  • 2. Deapril-ST for senile dementia.
    Med Lett Drugs Ther; 1977 Jul; 19(15):61-2. PubMed ID: 327247
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the effectiveness of dihydroergotoxine (DHET) in the treatment of chronic cerebral ischemia syndromes in elderly patients].
    Derejczyk J; Panuś K
    Wiad Lek; 1986 Jun; 39(12):818-24. PubMed ID: 3535261
    [No Abstract]   [Full Text] [Related]  

  • 4. Dihydroergotoxine: 6-mg versus 3-mg dosage in the treatment of senile dementia. Preliminary report.
    Yesavage JA; Hollister LE; Burian E
    J Am Geriatr Soc; 1979 Feb; 27(2):80-2. PubMed ID: 762369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relieving select symptoms of the elderly.
    Nelson JJ
    Geriatrics; 1975 Mar; 30(3):133-9, 142. PubMed ID: 803912
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the effectiveness and tolerance of dihydroergotoxine and alpha methyldopa in the therapy of arterial hypertension in the elderly with senile cerebral insufficiency].
    Bergamasco B; Scarzella L; Turri D
    Recenti Prog Med; 1987 Apr; 78(4):166-70. PubMed ID: 3628936
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of subjective tolerance of hydergine specific and hydergine in gerontologic therapy].
    Ronge J; Dennler HJ
    Med Welt; 1982 Oct; 33(42):1485-9. PubMed ID: 6757638
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of twice standard dosage of neuroactive drugs in dementia. A preliminary report.
    Knox J; Hindmarch I; Wallace M
    Br J Clin Pract; 1984 Sep; 38(9):313-5. PubMed ID: 6477811
    [No Abstract]   [Full Text] [Related]  

  • 9. Design aspects of clinical trials with ergot alkaloids: a comparison of two geriatric behavioral rating scales.
    Yesavage JA; Adey M
    Adv Biochem Psychopharmacol; 1980; 23():357-62. PubMed ID: 7395622
    [No Abstract]   [Full Text] [Related]  

  • 10. Ergoloid mesylates for senile dementias: unanswered questions.
    Hollister LE; Yesavage J
    Ann Intern Med; 1984 Jun; 100(6):894-8. PubMed ID: 6372566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Controlled multicenter clinical studies on the effect of (-)eburnamonine versus placebo in patients with chronic senile cerebral insufficiency of medium significance].
    Aveni-Casucci MA; Canal N; Corsico R; Passeri M; Porro A; Ventura A
    G Clin Med; 1983; 64(9-10):372-94. PubMed ID: 6363189
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of the cerebral metabolic enhancers in the treatment of senile dementia.
    Branconnier RJ
    Psychopharmacol Bull; 1983; 19(2):212-9. PubMed ID: 6408682
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methodology of a controlled trial of dihydroergotoxine in acquired intellectual impairment in the adult].
    Dartigues JF; Père JJ
    Presse Med; 1983 Dec; 12(48):3173-5. PubMed ID: 6228936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids.
    Jansen W; Bruckner GW; Jansen P
    J Int Med Res; 1985; 13(1):48-53. PubMed ID: 3884411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydergine-thioridazine combination in the treatment of psychopathological states in old age.
    Predescu V; Giurezu T; Tudorache D; Nica S; Ionescu R; Nicolschi L; Nitrurad A; Popvici E; Curelaru S
    Act Nerv Super (Praha); 1974 Aug; 16(3):237-8. PubMed ID: 4214302
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
    Calisti G; Biscarini L; Miseo A
    Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled study of dihydroergotoxine in gerontopsychiatric patients.
    Slánská J
    Act Nerv Super (Praha); 1989 Apr; 31(1):53-5. PubMed ID: 2782002
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug therapy of disorders of cerebral performance. Randomized comparative study of dihydroergotoxine and Ginkgo biloba extract].
    Gerhardt G; Rogalla K; Jaeger J
    Fortschr Med; 1990 Jun; 108(19):384-8. PubMed ID: 2199358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing senile dementia: hope for the future.
    Kent S
    Geriatrics; 1981 Sep; 36(9):130, 133, 135-6. PubMed ID: 7274675
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of organic psychosyndrome with hydergine and digitalis. A component study using double blind technics].
    Pfeiff E; Schlegel HE; Seus R; Dennler HJ; Kugler J
    Med Welt; 1980 Sep; 31(39):1403-7. PubMed ID: 7005587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.